婴幼儿心胸外科手术中间歇静脉对乙酰氨基酚与持续吗啡的比较:多中心随机对照试验
该多中心、随机、双盲、对照试验在荷兰和比利时的4个三级PICU开展,纳入0-3岁体外循环心脏手术患儿,比较持续吗啡与间歇静脉对乙酰氨基酚作为主要镇痛药(术毕均先给予100 mcg/kg吗啡负荷量,NRS疼痛评分超过预定界值时给补救吗啡)。最终分析194例(对乙酰氨基酚组102例,吗啡组106例),对乙酰氨基酚组术后48小时体重校正累积吗啡用量中位数145.0 mcg/kg,吗啡组692.6 mcg/kg,降低79%(P<0.001);两组补救吗啡用量相似(p=0.38);NRS评分≥4的比例差异-3.1%(95%CI -16.6-10.3%),证实对乙酰氨基酚非劣效。结论认为对乙酰氨基酚作为主要镇痛药可大幅减少吗啡用量且镇痛效果相当。
要点
- 0-3岁体外循环心脏术后,间歇静脉对乙酰氨基酚组48小时累积吗啡用量中位数145.0 mcg/kg,持续吗啡组692.6 mcg/kg,降低79%(P<0.001)。
- 两组补救吗啡用量相似(p=0.38),NRS评分≥4的比例差异-3.1%(95%CI -16.6-10.3%),非劣效成立。
- 术毕均先给予100 mcg/kg吗啡负荷量,NRS超过预定界值时给补救吗啡。
- 最终分析194例(对乙酰氨基酚组102例,吗啡组106例),从208例纳入患儿中排除14例未开始研究药物者。
适用人群与场景
- 0-3岁接受体外循环心脏手术的患儿,术后入住三级PICU。
- 研究在荷兰和比利时的4个三级PICU开展,纳入时间为2016年3月至2020年7月。
诊断标准与关键阈值
- 以NRS疼痛评分超过预定界值作为给予补救吗啡的指征。
- 非劣效分析以NRS疼痛评分≥4的患者比例为目标,非劣效界值为20%。
处置流程与药物剂量
- 术毕给予吗啡负荷量100 mcg/kg。
- 对乙酰氨基酚组:间歇静脉对乙酰氨基酚作为主要镇痛药(原文未写明具体剂量与频次)。
- 吗啡组:持续吗啡作为主要镇痛药(原文未写明具体剂量与频次)。
- NRS疼痛评分超过预定界值时给予补救吗啡。
研究设计与关键结果
- 多中心、随机、双盲、对照试验,在荷兰和比利时的4个三级PICU开展,筛查828例,最终纳入208例,其中315例父母未同意、305例因各种原因排除;208例中14例在开始研究药物前退出,最终分析194例(对乙酰氨基酚组102例,吗啡组106例)。
- 主要终点:术后48小时体重校正累积吗啡用量中位数,对乙酰氨基酚组145.0(IQR 115.0-432.5)mcg/kg vs 吗啡组692.6(IQR 532.7-856.1)mcg/kg,对乙酰氨基酚组降低79%(P<0.001)。
- 补救吗啡用量两组相似(p=0.38)。
- NRS疼痛评分≥4的患者比例差异-3.1%(95%CI -16.6-10.3%),证实对乙酰氨基酚非劣效。
证据类型、等级与局限
- 证据类型:多中心随机双盲对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在0-3岁体外循环心脏手术患儿中,间歇静脉对乙酰氨基酚作为主要镇痛药可使术后48小时体重校正累积吗啡用量中位数降低79%,且镇痛效果相当,对乙酰氨基酚作为主要镇痛药具有等效性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To determine whether intermittent intravenous (IV) paracetamol as primary analgesic would significantly reduce morphine consumption in children aged 0-3 years after cardiac surgery with cardiopulmonary bypass.
METHODS: Multi-center, randomized, double-blinded, controlled trial in four level-3 Pediatric Intensive Care Units (PICU) in the Netherlands and Belgium. Inclusion period; March 2016-July 2020. Children aged 0-3 years, undergoing cardiac surgery with cardiopulmonary bypass were eligible. Patients were randomized to continuous morphine or intermittent IV paracetamol as primary analgesic after a loading dose of 100 mcg/kg morphine was administered at the end of surgery. Rescue morphine was given if numeric rating scale (NRS) pain scores exceeded predetermined cutoff values. Primary outcome was median weight-adjusted cumulative morphine dose in mcg/kg in the first 48 h postoperative. For the comparison of the primary outcome between groups, the nonparametric Van Elteren test with stratification by center was used. For comparison of the proportion of patients with one or more NRS pain scores of 4 and higher between the two groups, a non-inferiority analysis was performed using a non-inferiority margin of 20%.
RESULTS: In total, 828 were screened and finally 208 patients were included; parents of 315 patients did not give consent and 305 were excluded for various reasons. Fourteen of the enrolled 208 children were withdrawn from the study before start of study medication leaving 194 patients for final analysis. One hundred and two patients received intermittent IV paracetamol, 106 received continuous morphine. The median weight-adjusted cumulative morphine consumption in the first 48 h postoperative in the IV paracetamol group was 5 times lower (79%) than that in the morphine group (median, 145.0 (IQR, 115.0-432.5) mcg/kg vs 692.6 (IQR, 532.7-856.1) mcg/kg; P < 0.001). The rescue morphine consumption was similar between the groups (p = 0.38). Non-inferiority of IV paracetamol administration in terms of NRS pain scores was proven; difference in proportion - 3.1% (95% CI - 16.6-10.3%).
CONCLUSIONS: In children aged 0-3 years undergoing cardiac surgery, use of intermittent IV paracetamol reduces the median weight-adjusted cumulative morphine consumption in the first 48 h after surgery by 79% with equal pain relief showing equipoise for IV paracetamol as primary analgesic. Trial Registration Clinicaltrials.gov, Identifier: NCT05853263; EudraCT Number: 2015-001835-20.
参考来源
- Zeilmaker-Roest G, de Vries-Rink C, van Rosmalen J, et al. Intermittent intravenous paracetamol versus continuous morphine in infants undergoing cardiothoracic surgery: a multi-center randomized controlled trial. Crit Care. 2024. PMID: 38689310. doi:10.1186/s13054-024-04905-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。